Form 8-K - Current report:
SEC Accession No. 0001104659-17-040686
Filing Date
2017-06-21
Accepted
2017-06-21 16:45:53
Documents
1
Period of Report
2017-06-21
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K a17-15503_18k.htm 8-K 70435
  Complete submission text file 0001104659-17-040686.txt   71666
Mailing Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY
Business Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37368 | Film No.: 17923285
SIC: 2836 Biological Products, (No Diagnostic Substances)